National Health Investors (NYSE:NHI) Posts Quarterly Earnings Results, Misses Expectations By $0.42 EPS

National Health Investors (NYSE:NHI) issued its earnings results on Tuesday. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42), Zacks reports. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The business had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. During the same period in the prior year, the business posted $1.08 EPS. The business’s revenue was up 1.7% on a year-over-year basis. National Health Investors updated its FY24 guidance to $4.43-$4.44 EPS and its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Stock Up 3.8 %

Shares of NYSE:NHI traded up $2.88 during midday trading on Thursday, reaching $79.64. The company had a trading volume of 451,071 shares, compared to its average volume of 194,790. The stock has a market capitalization of $3.46 billion, a P/E ratio of 27.07, a PEG ratio of 5.05 and a beta of 1.05. The stock’s fifty day moving average price is $80.38 and its 200-day moving average price is $73.16. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. National Health Investors has a one year low of $49.25 and a one year high of $86.13.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 4.52%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is currently 122.45%.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of recent research reports. Truist Financial boosted their price objective on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and upped their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Finally, Bank of America started coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, National Health Investors has an average rating of “Moderate Buy” and an average target price of $73.29.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.